48,335 Shares in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Acquired by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. bought a new position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 48,335 shares of the company’s stock, valued at approximately $259,000. A number of other institutional investors have also […]
Balyasny Asset Management L.P. bought a new position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 48,335 shares of the company’s stock, valued at approximately $259,000. A number of other institutional investors have also […]
